Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

Primo N. Lara,Catherine Tangen,Elisabeth I. Heath,Shuchi Gulati,Mark N. Stein,Maxwell Meng,Ajjai Shivaram Alva,Sumanta K. Pal,Igor Puzanov,Joseph I. Clark,Toni K. Choueiri,Neeraj Agarwal,Robert Uzzo,Naomi B. Haas,Timothy W. Synold,Melissa Plets,Ulka N. Vaishampayan,Brian M. Shuch,Seth Lerner,Ian M. Thompson,Christopher W. Ryan

EUROPEAN UROLOGY（2024）

Cited 0|Views37
Key words
Adjuvant,Everolimus,High risk,Kidney cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined